
Loading, please wait...

Loading, please wait...

The management of atrial fibrillation (AF) often requires a dual approach: rhythm control and stroke prevention. Recently, the "one-stop" procedure—combining catheter ablation (CA) with left atrial appendage occlusion (LAAO)—has gained traction. However, new research suggests that clinicians must remain vigilant regarding the residual shunt risk LAAO in patients with a history of cerebral infarction. While the procedure remains safe and effective for rhythm control, stroke survivors may face unique anatomical or physiological challenges that influence device success.
A retrospective study analyzed 242 patients undergoing the combined procedure, comparing those with and without a prior stroke. Initially, researchers found that procedural success rates were comparable between the two groups. Specifically, stroke and non-stroke patients achieved similar levels of freedom from AF recurrence. This suggests that a history of stroke does not inherently hinder the mechanical success of the ablation or the initial deployment of the occluder device.
Nevertheless, a significant disparity emerged during the 45-day follow-up. The incidence of residual shunts was notably higher in the stroke group (5.3%) compared to the non-stroke group (0%). Furthermore, the study identified a critical interaction between prior stroke history and the specific type of LAAO device used. Consequently, the residual shunt risk LAAO appears to be highly dependent on individual device selection for this specific patient population.
The discovery of a device-specific interaction is particularly relevant for clinical practice. It suggests that certain occluders may perform better in the remodeled left atrial environments often seen in stroke survivors. Because residual shunts are known to increase the risk of ischemic events, minimizing these leaks is paramount. Therefore, physicians should prioritize individualized device selection to optimize long-term safety. Future prospective trials are necessary to determine which specific device designs offer the best protection against leaks in high-risk stroke cohorts.
No, the study showed that procedural success and mid-term rhythm control (freedom from AF) were comparable between patients with and without a history of stroke.
The study indicates a significant interaction between prior stroke history and the type of LAAO device used, suggesting that anatomical variations or tissue characteristics in stroke survivors may influence how certain devices seal the appendage.
Clinicians should consider individualized device selection and rigorous post-procedural monitoring, as the risk of residual shunts is significantly higher in this population.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Ren H et al. Prior Stroke Increases Residual Shunt Risk After Combined Ablation and LAAO: A Device-Specific Interaction. Pacing Clin Electrophysiol. 2026 May 17. doi: 10.1111/pace.70254. PMID: 42143608.
Phillips KP et al. Combined catheter ablation and left atrial appendage closure: Patient selection and procedural considerations. J Cardiovasc Electrophysiol. 2022;33(5):980-989.
Hindricks G et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation. Eur Heart J. 2021;42(5):373-498.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A new study reveals that while combined ablation and LAAO is safe, prior stroke history significantly increases the risk of post-procedural residual shunts....
3 months ago

Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today